Surgery Doctors in Anniston, AL Accepting Medicare

4 Surgery doctors found. Showing 1 - 4

Dr. Keith Patrick Smith, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 901 Leighton Ave, Suite 705, Anniston, AL 36207 Phone: 256-231-1322    Fax: 256-231-1324

Keith Alan Barrett, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1900 Leighton Ave, Suite 201, Anniston, AL 36207 Phone: 256-235-8887    Fax: 256-770-4770

Lei Liu, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1901 Leighton Ave, Anniston General Surgery Center, Anniston, AL 36207 Phone: 256-240-9660    Fax: 256-240-9636

John Daniel Kasper, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 171 Town Center Dr, Anniston, AL 36205 Phone: 256-237-1624    Fax: 256-241-2277

News Archive

Machine learning model accurately classifies the stages of bladder cancer

The invasive and expensive diagnosis process of bladder cancer, which is one of the most common and aggressive cancers in the United States, may be soon helped by a novel non-invasive diagnostic method thanks to advances in machine learning research at the San Diego Supercomputer Center, Moores Cancer Center, and CureMatch Incorporated.

Search for gene search for sporadic amyotrophic lateral sclerosis

Though it's the more common form of the disease, sporadic Amyotrophic Lateral Sclerosis (ALS), which affects roughly 90 percent of those living with the fatal neurodegenerative illness, has been the one less studied, simply because, unlike familial ALS, no genes have turned up.

ZS Pharma starts patient enrollment in ZS-9 Phase 3 trial for treatment of hyperkalemia

ZS Pharma, a specialty pharmaceutical company developing novel treatments for kidney, cardiovascular and liver disorders, today announced that it has begun enrolling patients in ZS004, its second Phase 3 clinical trial of ZS-9, a novel investigational treatment for hyperkalemia.

New DNA analysis may guide personalized management of hepatocellular carcinoma

Detection of small fragments of tumor DNA, known as circulating tumor DNA, in a patient's pre-surgery serum samples predicts early recurrence of hepatocellular carcinoma and may guide treatment, according to a study published in Cellular and Molecular Gastroenterology and Hepatology, the basic and translational science journal of the American Gastroenterological Association.

Health Management Associates signs a five-year medical transcription services contract with Transcend

TRANSCEND SERVICES, INC. (NASDAQ: TRCR), the third largest provider of medical transcription services to the U.S. healthcare market, announced today that it has entered into a five-year single-source contract to provide medical transcription services to Health Management Associates, Inc. (NYSE: HMA) ("HMA").

Read more Medical News

› Verified 2 days ago